Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Katz

Showing results (611-620 of 749) with videos related to

Pageof 75
Sort By:
The Journal of Surgical Research|February 9, 2021
Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care InitiativeCasey J Allen, Jarrod S Eska, Nikhil G Thaker, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|July 7, 2022
Comparative analysis of opioid use between robotic and open pancreatoduodenectomyRussell G Witt, Yuki Hirata, Laura R Prakash, et al.
Annals of Surgical Oncology|September 10, 2015
The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative TherapyChristina L Roland, Matthew H G Katz, Ching-Wei D Tzeng, et al.
The Journal of Surgical Research|March 20, 2022
Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After PancreatectomyRussell G Witt, Timothy E Newhook, Laura R Prakash, et al.
Annals of Surgical Oncology|October 30, 2014
Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancerChristina L Roland, Anthony D Yang, Matthew H G Katz, et al.
Journal of Patient-Reported Outcomes|May 17, 2023
Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trialEric K H Chan, Valerie Williams, Carla Romano, et al.
Biochimica Et Biophysica Acta|September 16, 2008
Human cerebral neuropathology of Type 2 diabetes mellitusPeter T Nelson, Charles D Smith, Erin A Abner, et al.
Frontiers in Pharmacology|September 4, 2023
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to actionRosanne Janssens, Liese Barbier, Mireille Muller, et al.
Annals of Surgery|January 3, 2020
Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic AdenocarcinomaGiampaolo Perri, Laura Prakash, Wei Qiao, et al.
Chest|June 6, 2016
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-ExtensionPhilip S Wells, Martin H Prins, Bennett Levitan, et al.
Pageof 75

Showing results (611-620 of 749) with videos related to

Sort By:
Pageof 75
The Journal of Surgical Research|February 9, 2021
Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care InitiativeCasey J Allen, Jarrod S Eska, Nikhil G Thaker, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|July 7, 2022
Comparative analysis of opioid use between robotic and open pancreatoduodenectomyRussell G Witt, Yuki Hirata, Laura R Prakash, et al.
Annals of Surgical Oncology|September 10, 2015
The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative TherapyChristina L Roland, Matthew H G Katz, Ching-Wei D Tzeng, et al.
The Journal of Surgical Research|March 20, 2022
Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After PancreatectomyRussell G Witt, Timothy E Newhook, Laura R Prakash, et al.
Annals of Surgical Oncology|October 30, 2014
Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancerChristina L Roland, Anthony D Yang, Matthew H G Katz, et al.
Journal of Patient-Reported Outcomes|May 17, 2023
Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trialEric K H Chan, Valerie Williams, Carla Romano, et al.
Biochimica Et Biophysica Acta|September 16, 2008
Human cerebral neuropathology of Type 2 diabetes mellitusPeter T Nelson, Charles D Smith, Erin A Abner, et al.
Frontiers in Pharmacology|September 4, 2023
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to actionRosanne Janssens, Liese Barbier, Mireille Muller, et al.
Annals of Surgery|January 3, 2020
Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic AdenocarcinomaGiampaolo Perri, Laura Prakash, Wei Qiao, et al.
Chest|June 6, 2016
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-ExtensionPhilip S Wells, Martin H Prins, Bennett Levitan, et al.
Pageof 75